Mikhail Ovanesov

FDA investigator

Appears on 4 documents from 2016 to 2023, most often at sites in Austria. Most often cites control of microbiological contamination (21 CFR 211.113).

4
Documents on file
3.3
Observations per 483
2016
First seen
2023
Most recent

What they cite most

From 11 observations

Activity by year

2016: 2, 2022: 1, 2023: 1

Where

Austria 1 · Denmark 1 · Sweden 1 · Washington 1

Is Mikhail Ovanesov coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Novo Nordisk A/SMay 4, 2023 · Kalundborg, Denmark
483 Takeda Manufacturing Austria AGJun 24, 2022 · WIEN, Austria
483 Octapharma ABOct 3, 2016 · Stockholm, Sweden
483 AGC Biologics, Inc.Apr 22, 2016 · Bothell, Washington

About this profile

What does Mikhail Ovanesov inspect?

Mikhail Ovanesov appears on 4 documents on file covering 4 sites, most often in Austria.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.100.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Mikhail Ovanesov is dated May 4, 2023.